Mayo Clinic researchers have developed organoid models to study uveal melanoma, one of the most common types of eye cancer in ...

Mayo Clinic researchers have developed organoid models to study uveal melanoma, one of the most common types of eye cancer in ...

Pancreas organoid gives new clues Using these organoids, the researchers discovered new information about how the pancreas develops. "The stem cell of the fetal pancreas is present longer than ...

This marks a significant milestone as SIGX1094 is the first pipeline drug discovered using AI and organoid disease model to enter clinical trials, and the first targeted therapy candidate to ...

Okomera is a biotech startup developing cutting-edge solutions for oncology drug discovery and will present their technology in SLAS 2025,in San Diego January 25 to 29, 2025. Okomera will showcase its ...

Bioinformatics allowed me to address these questions faster and with a broader perspective. The growing availability of public data facilitated this. However, the transition wasn’t easy. I tried many ...

Baylor College of Medicine's President and CEO, Dr. Paul Klotman discusses the state of the coronavirus in America and puts a special focus on the new Organoid Core Lab of Dr. Mary Estes and Dr. Sarah ...

Scientists optimize organoid culture growth and consistency with validated growth factor panels. Researchers can optimize organoid culture growth and consistency with panels of growth factors that are ...

Researchers from the Organoid group at the Hubrecht Institute have developed a new way to grow organoids. Organoids are tiny organs that are grown in the lab and mimic the original organ.

Organoid technology has lately risen to prominence as a critical tool for both basic and biomedical research. Embryonic stem cells (ESCs), induced pluripotent stem cells (iPSCs), and primary ...

Mayo Clinic researchers have developed organoid models to study uveal melanoma, one of the most common types of eye cancer in adults. Their goal is to use these models to better understand how this ...